Singapore’s biomedical sector is still strong thanks to its more liberal laws regarding embryonic stem cell research, says a prominent US-based professor.

Professor Shu Chien, of the University of California (San Diego) said there were fears that the Singapore biomed sector might suffer when the current US administration eased conditions last year, but it continues to flourish thanks to laws restricting access to embryonic stem cells in many US states (other than California). Singapore’s laws, which also reduce red tape for scientists, have encouraged more qualified individuals from many countries to seek employment there instead.

source & part-article: Straits Times